The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats

DOI: 10.1186/s12933-019-0849-6

Keywords: SGLT2 inhibitor, Empagliflozin, Hypertensive, Heart failure, Cardiac fibrosis, Hemodynamics, High-fat, PPARα, ACADM

Full-Text   Cite this paper   Add to My Lib

Abstract:

The animal grouping and time line of the experimental protoco

Full-Text